REMOPAIN®
Injection IV/IM
:: COMPOSITION ::
:: PHARMACOLOGY ::
:: PHARMACOKINETCS ::
Bioavailability has been reported to range from 80-100% following oral administration. T
max occurs within 30-60 minutes after oral or parenteral administration. Food decreases
the absorption rate, but not the extent of oral absorption. 99% of the ketorolac in plasma is
protein-bound, volume distribution (Vd) < 0.3 L/kg. Ketorolac is metabolised in liver, and
excreted through renal. The metabolites doesn’t have significant analgesic activity. The
elimination terminal half-life of ketorolac (t ½b) is ± 5 hours In geriatric patients,
absorption of ketorolac and plasma protein bound does not affect substantially, but the
plasma clearance is decreased (CL) (t ½b= 6-7 hours).In patients with renal impairment
the plasma clearance is decreased, it prolongs t½b (9-10 hours).Patients with alcoholic
cirrhosis shows a little increase of t½b and T max.
:: INDICATIONS ::
Ketorolac is indicated for the short-term (≤ 5 days) management of moderate and severe
acute pain that requires analgesia at the opioid level.
:: CONTRAINDICATIONS ::
:: SIDE EFFECTS ::
Side effect incidence increases proportionally with increasing dose of ketorolac. Severe
complications are caused by ketorolac therapy like ulcer, bleeding and gastrointestinal
perforation, post operative bleeding, acute renal failure, anaphylactic and anaphylactoid
reactions and hepatic failure must be keep on guard. Complications NSAID may be
serious, especially if administration of ketorolac out of recommended dose.The adverse
reactions listed below are reported as probably related to ketorolac in clinical trials.
:: INCIDENCE > 1% ::
:: INCIDENCE ≤ 1% ::
:: DRUG INTERACTION ::
There are no significant interactions between ketorolac and warfarin or heparin. Should be
used with cautiously and strictly monitored if administration of ketorolac for patients with
anticoagulant therapy.Combination of ketorolac tromethamine and other NSAIDs is not
recommended, because it would increase side effects potency.
Ketorolac Effects
interactions
Warfarin Protein binding of warfarin may be decreased slightly from
99.5% to 99.3%. It doesn’t change significantly
pharmacokinetics or pharmacodynamics profile. Protein
binding of ketorolac doesn’t change.
Heparin Prolong average bleeding time (placebo : 5.1 minutes; heparin:
6.0 minutes; heparin + ketorolac : 6.4 minutes).
Digoxin Protein binding of digoksin and ketorolac do not change.
Salicylate Protein binding of ketorolac was decreased from 99.2% to
97.5%, which would represent a potential two-fold increase in
plasma concentrations of unbound drug.
Ibuprofen Protein-binding doesn’t change.
Naproxen Protein-binding doesn’t change.
Piroxicam Protein-binding doesn’t change.
Acetaminophen Protein-binding doesn’t change.
Phenytoin Protein-binding doesn’t change.
Tolbutamide Protein-binding doesn’t change.
Furosemide Reduced diuretic response 20% (Mean sodium and urinary
output decreased 17%).
Probenecid Results in decreased clearance of ketorolac and significant
increases in ketorolac plasma levels (Total AUC increases ± 3
fold from 5.4 to 17.8 µg/hour/mL, t½ terminal increase ± 2 fold
from 6.6 to 15.1 hours. Concomitant use of ketorolac and
probenecid is contraindicated.
Lithium Inhibition of renal lithium clearance, leading to an increase in
plasma lithium concentration.
Methotrexate Methotrexate clearance is decreased, so that enhancing the
toxicity of methotrexate (because of NSAID). The effect of
Ketorolac on methotrexate clearance has not been studied.
Non-depolarizing Concomitant use of ketorolac and muscle relaxants have not
muscle relaxants formally studied, so that it must be used with caution.
ACE inhibitors Renal impairment risk will be increased, especially in volume-
depleted patients.
Antiepilectic drugs Convulsion attack is occurred (sporadic cases)
(phenytoin,
carbamazepine)
Psychoactive drugs Hallucinations
(fluoxetine, tiotixen,
alprazolam)
Morphine No detrimental interactions are observed. Do not mix ketorolac
and morphine in the same syringe.
There are no reports of combination between ketorolac and anti infections, antiemetic,
laxative, sedative, anxiolitic, corticosteroid, bronchodilator or hormon.No evidence (in
animal or human studies) which shows that ketorolac induces or inhibits hepatic enzymes
capable of metabolizing itself or other drugs.